Building Transparent and Inclusive ALS Trials: Best Practices in Early Access Programs (EAPs) & Open Label Extensions (OLEs)
Time: 3:30 pm
day: Conference Day Two PM
Details:
- Investigate how clear communication and data sharing between researchers, patients and caregivers can improve trust and engagement in EAPs and OLEs for more transparent trial design
- Highlighting the importance of early and meaningful patient involvement in shaping trial goals, eligibility criteria and logistics to ensure trials reflect patient priorities
- Exploring innovative approaches to minimize placebo duration and optimize trial design to balance scientific rigor with patient-centered outcomes
- Reshaping EAPs and OLEs with community-driven recommendations to ensure they meet the needs of patients and caregivers while advancing ALS research
